drugset / Trial / NCT04231279
Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This is a 3-year prospective study too identify the role of exocrine pancreatic insufficiency in patients with abdominal pain who are undergoing upper endoscopy. An endoscopic pancreatic function test (ePFT) with secretin will be performed in children undergoing routine investigative EGD. The goal of this study is to identify the role of exocrine pancreatic insufficiency in patients with abdominal pain who are undergoing upper endoscopy, who otherwise would be labelled as recurrent abdominal pain (RAP).
Timeline
- Start
- 2022-01-28
- Primary completion
- 2023-06-15
- Completion
- 2023-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Secretin | Other / unclassified | — | — |